Key Insights

Highlights

Success Rate

50% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 90/100

Termination Rate

37.5%

3 terminated out of 8 trials

Success Rate

50.0%

-36.5% vs benchmark

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results50% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (5)
P 4 (1)

Trial Status

Completed3
Terminated3
Unknown2

Trial Success Rate

50.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (8)

Research Network

Activity Timeline